Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493676 | SCV000582536 | uncertain significance | not provided | 2020-07-31 | criteria provided, single submitter | clinical testing | In-frame deletion/insertion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Institute of Human Genetics, |
RCV001262955 | SCV001441014 | uncertain significance | Arthrogryposis, distal, type 2B2 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003424045 | SCV004116856 | uncertain significance | TNNT3-related disorder | 2024-01-05 | no assertion criteria provided | clinical testing | The TNNT3 c.530_532delAGA variant is predicted to result in an in-frame deletion (p.Lys177del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0086% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |